Sort   by:  
 Page size 
ProteomicsProteomics results of mouse testis after NHWD870 treatment
NHWD870 is a small molecule compound targeting Brdt. Testicular proteomics data obtained after intragastric administration of NHWD870 to six-week-old mice.
ORGANISM(S): Mus musculus (Mouse) 
2023-05-10 | PXD028773 | Pride
Mouse Nhwd870 Testis Brdt 
UnknownThe novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice.
Not available
S-EPMC10157631 | biostudies-literature
Genomics
Transcriptomics of mouse testis after NHWD870 administration
PRJNA765522 | ENA
TranscriptomicsEffect of BET bromodomain inhibitor and/or mTOR inhibitor on transcriptome of small cell lung cancer patient-derived xenograft LX95 tumors
We report mTOR inhibitor (mTORi) is synergistic with BET inhibitor (BETi) in controlling tumor growth and inducing apoptosis in small cell lung cancer (SCLC) patient-derived xenograft (PDX) models. In this study, we studied impact of different treatment on whole-genome mRNA transcriptome in SCLC PDX...
ORGANISM(S): Homo sapiens 
2020-09-01 | GSE155923 | GEO
UnknownInhibition of BRD4 sensitizes NSCLC cells to osimertinib by suppressing APT1 and promoting MST1 palmitoylation.
Not available
S-EPMC12583557 | biostudies-literature
GenomicsEffect of BET bromodomain inhibitor and/or mTOR inhibitor on transcriptome of small cell lung cancer patient-derived xenograft LX95 tumors
Effect of BET bromodomain inhibitor and/or mTOR inhibitor on transcriptome of small cell lung cancer patient-derived xenograft LX95 tumors
PRJNA656183 | ENA
GenomicsBET Inhibitors Target the SCLC-N subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation
BET Inhibitors Target the SCLC-N subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation
PRJNA863671 | ENA
Sort   by:  
 Page size